Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1988 Aug;32(8):1208-12.
doi: 10.1128/AAC.32.8.1208.

Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP

Affiliations
Comparative Study

Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP

L E Nilsson et al. Antimicrob Agents Chemother. 1988 Aug.

Abstract

Mycobacterial growth was monitored by bioluminescence assay of mycobacterial ATP. Cultures of Mycobacterium tuberculosis H37Rv and of 25 clinical isolates of the same species were exposed to serial dilutions of ethambutol, isoniazid, rifampin, and streptomycin. A suppression of ATP, indicating growth inhibition, occurred for susceptible but not resistant strains within 5 to 7 days of incubation. Breakpoint concentrations between susceptibility and resistance were determined by comparing these results with those obtained by reference techniques. Full agreement was found in 99% of the assays with the resistance ratio method on Lowenstein-Jensen medium, and 98% of the assays were in full agreement with the radiometric system (BACTEC). A main advantage of the bioluminescence method is its rapidity, with results available as fast as with the radiometric system but at a lower cost and without the need for radioactive culture medium. The method provides kinetic data concerning drug effects within available in vivo drug concentrations and has great potential for both rapid routine susceptibility testing and research applications in studies of drug effects on mycobacteria.

PubMed Disclaimer

References

    1. J Antimicrob Chemother. 1982 Oct;10(4):351-4 - PubMed
    1. J Clin Microbiol. 1983 Sep;18(3):689-96 - PubMed
    1. J Clin Microbiol. 1983 Dec;18(6):1335-9 - PubMed
    1. Eur J Clin Microbiol. 1985 Dec;4(6):556-61 - PubMed
    1. Am Rev Respir Dis. 1977 Jun;115(6):1066-9 - PubMed

Publication types

MeSH terms

LinkOut - more resources